Adi Wilf-Yarkoni

7PUBLICATIONS
59CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Optical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2026
Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case-Control Study.

Tasneem Kab, Keshet Pardo, Mark A Hellmann

|Mar 08, 2026
Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients-A Population-Based, Matched Case-Control Study.

Keshet Pardo, Tasneem Kab, Mark A Hellmann

|Sep 29, 2025
Subunit-Specific Immunodominance in Clinically Distinct Populations With AChR+ Myasthenia Gravis: A Multiparametric Cross-Sectional Analysis.

Kfir Oved, Galit Denkberg, Lena Pinzur

|Aug 29, 2025
Outcomes After Acute Plasma Exchange for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Smathorn Thakolwiboon, Vyanka Redenbaugh, Bo Chen

|Dec 07, 2023
Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.

Adi Wilf-Yarkoni, Kristina Feldmann, Kerstin Rubarth

|Apr 08, 2021
Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis.

Adi Wilf-Yarkoni, Itay Lotan, Israel Steiner

Pageof 2

Frequent Collaborators

4 joint publications

Itay Lotan

2 joint publications

Hadas Stiebel-Kalish

2 joint publications

Keshet Pardo

1 joint publications

Kerstin Rubarth